Fluorescence-Based Biochemical Protease Assay Formats

A Practical Guide to Assay Development and High-Throughput Screening in Drug Discovery

Volumn , Issue , 2009, Pages 25-48

  Woelcke, Julian ^a   Hassiepen, Ulrich ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960498924     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1201/9781420070514-7     Document Type: Chapter

References (90)

1. Aibe, K. et al. 1996. Substrate specificity of recombinant osteoclast-specific cathepsin K from rabbits. Biol. Pharm. Bull. 19, 1026-1031.
2. Andrews, D.L. and Demidov, A.A. 1999. Resonance Energy Transfer. Chichester: John Wiley & Sons.
3. Angliker, H. et al. 1995. Internally quenched fluorogenic substrate for furin. Anal. Biochem. 224, 409-412.
4. Attucci, S. et al. 2002. Measurement of free and membrane-bound cathepsin G in human neutrophils using new sensitive fluorogenic substrates. Biochem. J. 366, 965-970.
5. Banks, P., Gosselin, M., and Prystay, L. 2000. Impact of a red-shifted dye label for high-throughput fluorescence polarization assays of G protein-coupled receptors. J. Biomol. Screen. 5, 329-334.
6. Barret, A.J. 2004. Bioinformatics of proteases in the MEROPS database. Curr. Opin. Drug Disc. Dev. 7, 334-341.
7. Barrett, A.J. and MacDonald, J.K. 1986. Nomenclature: protease, proteinase and peptidase. Biochem. J. 237, 935-940.
8. Berger, A. and Schechter, I. 1976. On the size of the active site in proteases I: papain. Biochem. Biophys. Res. Comm. 27, 157-162.
9. Bratanova, E.K. and Petkov, D.D. 1987. N-antraniloylation converts peptide p-nitroanilides into fluorogenic substrates of proteases without loss of their chromogenic properties. Anal. Biochem. 162, 213-218.
10. Burbaum, J.J. and Sigal, N.H. 1997. New technologies for high-throughput screening. Curr. Opin. Chem. Biol. 1. 72-78.
11. Cai, S.X. et al. 2001: Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay. Bioorg. Med. Chem. Lett. 11, 39-42.
12. Carmel, A., Kessler, E., and Yaron, A. 1977. Intramolecularly quenched fluorescent peptides as fluorogenic substrates of leucine aminopeptidase and inhibitors of clostridial aminopeptidase. Eur. J. Biochem. 73, 617-625.
13. Chen, R.F. 1968. DANSYL labeled proteins: determination of extinction coefficient and number of bound residues with radioactive dansyl chloride. Anal. Biochem. 25, 412-416.
14. Cheng Y.C. and Prusoff W.H. 1973. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50% inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3108.
15. Clegg, R.M. and Schneider, P.C. 1996. Fluorescence lifetime-resolved imaging microscopy: a general description of lifetime-resolved imaging measurements. In Fluorescence Microscopy and Fluorescent Probes, Slavik, J., Ed. New York: Plenum, pp. 15-33.
16. Comley, J. 2006. TR-FRET based assays: getting better with age. Drug Disc. World. Spring, 23-37.
17. Comley, J. 2007: TR-FRET-Based Assay Trends 2007. Cambridge, U.K. HTStec.
18. Copeland, R.A. 2000. Enzymes; a practical introduction to structure, mechanism, and data analysis. New York: Wiley-VCH.
19. Copeland, R. 2005. Evaluation of enzyme inhibitors in drug discovery. Hoboken: John Wiley & Sons.
20. Diamond, S.L. 2007. Methods for mapping protease specificity. Curr. Opin. Chem. Biol. 11, 46-51.
21. Doering, K. et al. 2009. A fluorescence lifetime-based assay for protease inhibitor profiling on human kallikrein 7. J. Biomol. Screen. 1, 1-9.
22. Eggeling, C. et al. 2003. Highly sensitive fluorescence detection technology currently available for HTS. Drug Disc. Today 8, 632-641.
23. Ferrer, M. et al. 2003: Miniaturizable homogeneous time-resolved fluorescence assay for carboxypeptidase B activity. Anal. Biochem. 317. 94-98.
24. Florentin, D., Sassi, A., and Roques, B.P. 1984: A highly sensitive fluorometric assay for enkephalinase, a neutral metalloendopeptidase that releases tryrosine-glycine-glycine from enkephalins. Anal. Biochem. 141, 62-69.
25. Flotow, H. et al. 2002. Development of a plasmepsin II fluorescence polarization assay suitable for highthroughput antimalarial drug discovery. J. Biomol. Screen. 7, 367-371.
26. Forster T. 1948. Zwischenmolekulare Energiewanderung und Fluoreszenz. Ann. Phys. 2, 55-75.
27. George, J. et al. 2003. Evaluation of an imaging platform during the development of a FRET protease assay. J. Biomol. Screen. 8, 72-80.
28. Gerhartz, B., Nistroj, A.J., and Demuth, H.U. 2002. Enzyme classes and mechanisms. In Proteinase and Peptidase Inhibition, Smith, H.J. and Simons, C., Eds. London: Taylor & Francis, pp. 1-20.
29. Gershkovich, A.A. and Kholodovych, V.V. 1996. Fluorogenic substrates for proteases based on intramolecular fluorescence energy transfer (IFETS). J. Biochem. Biophys. Meth. 33, 135-162.
30. Grant, S.K., Sklar, J.G., and Cummings, R.T. 2002. Development of novel assays for proteolytic enzymes using rhodamine-based fluorogenic substrates. J. Biomol. Screen. 7, 531-540.
31. Graves, P. et al. 2005. Whatever happened to fluorescence lifetime? Poster presented at 11th Annual SBS Conference, Geneva.
32. Graves, P. et al. 2006. Discriminating fluorescence lifetime assays for screening. Poster presented at 12th Annual SBS Conference, Seattle.
33. Graziano, V. et al. 2006: Enzymatic activity of the SARS coronavirus main proteinase dimer. FEBS Lett. 580, 2577-2583.
34. Gurtu, V., Kain, S.R., and Zhang, G. 1997. Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal. Biochem. 251, 98-102.
35. Harris, J.L. et al. 2000. Rapid and general profiling of protease specificity by using combinatorial fluorogenic substrate libaries. Proc. Natl. Acad. Sci. USA, 7754-7759.
36. Hassiepen, U. et al. 2007. A sensitive fluorescence intensity assay for deubiqitinating proteases using ubiquitinrhodamine110-glycine as substrate. Anal. Biochem. 371, 201-207.
37. Hennig, A. et al. 2007. Design of peptide subsrates for nanosecond time-resolved fluorescence assays of proteases: 2,3-diazabicycle[2.2.2]oct-2-ene as a non-invasive fluorophore. Anal. Biochem. 360, 255-265.
38. Hennig, A. et al. 2006. Nanosecond time-resolved fluorescence protease assays. Chem. BioChem. 7, 733-737.
39. Horton, R.A. et al. 2007. A substrate for deubiquitinating enzymes based on time-resolved fluorescence energy transfer between terbium and yellow fluorescent protein. Anal. Biochem. 360, 138-143.
40. Jager, S., Brand, L., and Eggeling, C. 2003. New fluorescence techniques for high-throughput drug discovery. Curr. Pharm. Biotechnol. 4, 463-467.
41. Karvinen, J. et al. 2002. Homogeneous time-resolved fluorescence quenching assay (LANCE) for caspase 3. J. Biomol. Screen. 7, 223-231.
42. Knight, C.G., Willenbrock, F., and Murphy, G. 1992. A novel coumarin-labelled peptide for sensitive continuous assays of the metalloproteinases. FEBS Lett. 296, 263-266.
43. Konstantinidis, A.K. et al. 2007. Longer wavelength fluorescence energy transfer depsipeptide substrates for hepatitis C virus NS3 protease. Anal. Biochem. 368, 156-167.
44. Lakowicz, J.R. 2006. Principles of Fluorescence Spectroscopy. New York: Springer.
45. Lauer-Fields, J.L. et al. 2007. Screening of potential a disintegrin and metalloproteinase with thrombospondin motifs-4 inhibitors using a collagen model fluorescence resonance energy transfer substrate. Anal Biochem. 373, 43-51.
46. Lecaille, F. et al. 2003. Probing cathepsin K activity with a selective substrate spanning its active site. Biochem. J. 375, 307-312.
47. Leissring, M.A. et al. 2003. Kinetics of amyloid b-protein degradation determined by novel fluorescence polarization-based assays. J. Biol. Chem. 278, 37314-37320.
48. Lestienne, P. and Bieth, J.G. 1980: Activation of human leukocyte elastase activity by excess substrate, hydrophobic solvents and ionic strengths. J. Biol. Chem. 255, 9289-9294.
49. Levine, L.M. et al. 1997. Measurement of specific protease activity utilizing fluorescence polarization. Anal. Biochem. 247, 83-88.
50. Li, H.X. et al. 2007. Substrate specificity of human kallikreins 1 and 6 determined by phage display. Prot. Sci. 17, 664-672.
51. Liu, J. et al. 1999: Fluorescent molecular probes V: a sensitive caspase-3 substrate for fluorometric assays. Bioorg. Med. Chem. Lett. 9, 3231-3236.
52. Lopez-Calle, E., Fries, J., and Jungmann, J. 2002. Methods and means for detecting enzymatic cleavage and linkage reactions. Patent WO/2002/059352.
53. Malfroy, B. and Burnier, J. 1987. New substrates for enkephalinase (neutral endopeptidase) based on fluorescence energy transfer. Biochem. Biophys. Res. Comm. 143, 58-66.
54. Mao, S.S. et al. 2008. A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3-4A protease at low enzyme concentrations. Anal Biochem. 373, 1-8.
55. Marks, B.D. et al. 2005. Multiparameter analysis of a screen for progesterone receptor ligands: comparing fluorescence lifetime and fluorescence polarization measurements. Assay Drug Devel. Technol. 3, 613-622.
56. Marme, N. et al. 2004. Highly sensitive protease assay using fluorescence quenching of peptide probes based on photoinduced electron transfer. Angew. Chem. Int. Ed. 43, 3798-3801.
57. Mathis, G. 1999. HTRF technology. J. Biomol. Screen. 4, 309-314.
58. Mayer-Almes, F.J. and Auer, M. 2000. Enzyme inhibition assays using fluorescence correlation spectroscopy: a new algorithm for the derivation of kcat/KM and Ki values at substrate concentrations much lower than the Michaelis constant. Biochemistry, 39, 13261-13268.
59. Moger, J. et al. 2006. The application of fluorescence readouts in high-throughput screening. J. Biomol. Screen. 11, 765-772.
60. Nishino, N., Makinose, Y., and Fujimoto, T. 1992. 2-Aminobenzoyl-peptide-2,4-dinitroanilinoethylamides: facile fluorescent detection system for sequence specific proteases. Chem. Lett. 1, 77-80.
61. Nomura, A.M. et al. 2006. One functional switch mediates reversible and irreversible inactivation of a herpesvirus protease. Biochemistry 45, 3572-3579.
62. O’Connor, D.V. and Phillips, D. 1984. Time-Correlated Single Photon Counting. New York: Academic Press.
63. Okun, I. et al. 2006. Screening for caspase-3 inhibitors: a new class of potent small-molecule inhibitors of caspase 3. J. Biomol. Screen. 11, 277-285.
64. Owicki, J.C. 2000. Fluorescence polarization and anisotropy in high-throughput screening: perspectives and primer. J. Biomol. Screen. 5, 297-306.
65. Palmier M.O. and Van Doren S.R. 2007. Rapid determination of enzyme kinetics from fluorescence: overcoming the inner filter effect. Anal Biochem. 371, 43-51.
66. Pham, W. et al. 2004. Developing a peptide-based near-infrared molecular probe for protease sensing. Bioconj. Chem. 15, 1403-1407.
67. Pope, A.J., Haupts, U.M., and Moore, K.J. 1999. Homogeneous fluorescence readouts from miniaturized highthroughput screening: theory and practice. Drug Disc. Today 4, 350-362.
68. Preaudat, M. et al. 2002: A homogeneous caspase-3 activity assay using HTRF technology. J. Biomol. Screen. 7, 267-274.
69. Rawlings, N.D., Morton, F.R., and Barrett, A.J. 2006. MEROPS: the peptidase database. Nucl. Acid Res. 34, D270-D272.
70. Rehault, S. et al. 1999. New sensitive fluorogenic substrates for human cathepsin G based on the squence of serpin-reactive site loops. J. Biol. Chem. 274, 13810-13817.
71. Richardson, P.L. 2002. The determination and use of optimized protease substrates in drug discovery and development. Curr. Pharm. Dis. 8, 2559-2281.
72. Schilling, O. and Overall, C.M. 2008. Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites. Nat. Biotechnol. 26, 685-694.
73. Silverman, L., Campbell, R., and Broach, J.R. 1998. New assay technologies for high-throughput screening. Curr Opin. Chem. Biol. 2, 397-403.
74. Smith, J.A., West, R.M., and Allen, M. 2004. Acridones and quinacridones: novel fluorophores for fluorescence lifetime studies. J. Fluoresc. 14, 151-171.
75. St. Hilaire, P.M. et al. 1999. Fluorescence-quenched solid phase combinatorial libraries in the characterization of cysteine protease substrate specificity. J. Comb. Chem. 1, 509-524.
76. Stambolieva, N.A., Ivanov, I.P., and Yomtova, V.M. 1992. N-antraniloyl-Ala-Ala-Phe-4-nitroanilide, a highly sensitive substrate for subtilisins. Arch. Biochem. Biophys. 294, 703-706.
77. Stein, R.L. and Strimpler, A.M. 1987. Catalysis by human leukocyte elastase: aminolysis of acyl enzymes by amino acid amides and peptides. Biochemistry, 26, 2238-2242.
78. Tanaka, T. et al. 1985. Human leukocyte cathepsin G: substrate mapping with 4-nitroanilides, chemical modification and effect of possible cofactors. Biochemistry, 24, 2040-2047.
79. Tirat, A. et al. 2005. Synthesis and characterization of fluorescent ubiquitin derivatives as highly sensitive substrates for deubiquitinating enzymes UCH-L3 and USP-2. Anal. Biochem. 343, 244-255.
80. Toth, M.V. and Marshall, G.R. 1990. A simple, continuous fluorometric assay for HIV protease. Int. J. Pept. Protein Res. 36, 544-550.
81. Turconi S. et al. 2001a. Developments in fluorescence lifetime-based analysis for ultra-HTS. Drug Disc. Today 6, 27-39.
82. Turconi, S. et al. 2001b. Real experience of uHTS: a prototypic 1536-well fluorescence anisotropy-based uHTS screen and application of well-level quality control procedures. J. Biomol. Screen. 6, 275-290.
83. Turek-Etienne, T.C. et al. 2003. Evaluation of fluorescent compound interference in 4 fluorescence polarization assays: 2 kinases, 1 protease and 1 phosphatase. J. Biomol. Screen. 8, 176-184.
84. Turk, B. 2006. Targeting proteases: success, failures and future prospects. Nat. Rev. Drug Disc. 5, 785-799.
85. Turro, N.J. 1965. Molecular Photochemistry. New York: W.A. Benjamin.
86. Van der Meer, B.W., Coker, G.I., and Chen, S.Y. 1994. Resonance Energy Transfer: Theory and Data. New York: VCH.
87. Von Geldren, W.T., Holleman, W.H., and Opgenorth, T.J. 1991. A fluorescence assay for endothelin-converting enzyme. Pep. Res. 4, 32-35.
88. Wang, G.T. et al. 1990. Design and synthesis of new fluorogenic HIV protease substrates based on resonance energy transfer. Tetrahedron Lett. 31, 6493-6496.
89. Xia, L. et al. 1999. Localization of rat cathepsin K in osteoclasts and resorption pits: inhibition of bone resorption cathepsin K-activity by peptidyl vinyl sulfones. Biol. Chem. 380, 679-687.
90. Zou, J. et al. 2005. ADAM33 enzyme properties and substrate specificity. Biochemistry 44, 4247-4256.